LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Airway Obstruction D000402 13 associated lipids
Stomach Ulcer D013276 75 associated lipids
Adenocarcinoma D000230 166 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Gastritis D005756 27 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Celik D et al. Cysteinyl leukotrienes in exhaled breath condensate of smoking asthmatics. 2013 Clin. Chem. Lab. Med. pmid:23045385
Guan W et al. Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes. 2013 J. Allergy Clin. Immunol. pmid:23040886
Tang SS et al. Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice. 2013 Neuropharmacology pmid:22982445
Provost V et al. Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells. 2012 PLoS ONE pmid:22952702
Pelclová D et al. Leukotrienes B4, C4, D4 and E4 in the exhaled breath condensate (EBC), blood and urine in patients with pneumoconiosis. 2012 Ind Health pmid:22785421
Huang XQ et al. Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1. 2012 J Neuroinflammation pmid:22734808
Forsell PK et al. Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases. 2012 Lipids pmid:22684912
Dahlén B et al. Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma. 2012 Eur. J. Clin. Pharmacol. pmid:22457014
Guan W et al. Leukotriene D4 bronchial provocation test: methodology and diagnostic value. 2012 Curr Med Res Opin pmid:22435894
Parmentier CN et al. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1. 2012 J. Allergy Clin. Immunol. pmid:22391114
Rehn M and Diener M Cysteinyl leukotrienes mediate the response of submucosal ganglia from rat colon to bradykinin. 2012 Eur. J. Pharmacol. pmid:22366210
Dannull J et al. Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function. 2012 Blood pmid:22323449
Muccitelli RM et al. Cysteinyl leukotriene receptor assays. 2001 Curr Protoc Pharmacol pmid:22293965
Ahmed T et al. Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence. 2012 Respir. Res. pmid:22269021
Matsumoto H et al. Interleukin-13 enhanced Ca2+ oscillations in airway smooth muscle cells. 2012 Cytokine pmid:22078634
Drost AC et al. The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia. 2012 Leuk. Lymphoma pmid:21936770
Ni NC et al. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice. 2011 J. Pharmacol. Exp. Ther. pmid:21903747
Luo H et al. [Changes of leukotriene D4 in nasal discharge and plasma of patients with persistent allergic rhinitis and the effects of antihistamine]. 2011 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21761705
Mizutani N et al. Effect of Ganoderma lucidum on pollen-induced biphasic nasal blockage in a guinea pig model of allergic rhinitis. 2012 Phytother Res pmid:21698671
Rehni AK and Singh TG Modulation of leukotriene D4 attenuates the development of seizures in mice. 2011 Prostaglandins Leukot. Essent. Fatty Acids pmid:21641195
Chen LY et al. Cooperative and redundant signaling of leukotriene B4 and leukotriene D4 in human monocytes. 2011 Allergy pmid:21605126
Daniele S et al. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands. 2011 J. Pharmacol. Exp. Ther. pmid:21531793
Cai BL et al. [Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells]. 2011 Zhejiang Da Xue Xue Bao Yi Xue Ban pmid:21488208
Haneda Y et al. Leukotriene D4 enhances tumor necrosis factor-α-induced vascular endothelial growth factor production in human monocytes/macrophages. 2011 Cytokine pmid:21482134
Huang SC Leukotriene-induced contraction is mediated by cysteinyl leukotriene receptor CysLT1 in guinea pig fundus but by CysLT1 and CysLT2 in antrum. 2011 Life Sci. pmid:21396378
Dartt DA et al. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. 2011 J. Immunol. pmid:21357260
Xu L et al. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings. 2010 Pharmazie pmid:21105577
Brochu-Bourque A et al. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor. 2011 J. Pharmacol. Exp. Ther. pmid:20966037
McGovern T et al. LTDâ‚„ induces HB-EGF-dependent CXCL8 release through EGFR activation in human bronchial epithelial cells. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20889674
Hayashi S et al. Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships. 2010 Bioorg. Med. Chem. pmid:20875743
Zhou Y et al. Circulating LTD4 in patients with hepatocellular carcinoma. 2011 Tumour Biol. pmid:20820981
Sakai H et al. Augmented venous responsiveness to leukotriene D(4) in nasal septal mucosae of repeatedly antigen-challenged rats. 2010 Eur. J. Pharmacol. pmid:20638382
Kim MH et al. Effect of leukotriene D4 on mouse embryonic stem cell migration and proliferation: involvement of PI3K/Akt as well as GSK-3β/β-catenin signaling pathways. 2010 J. Cell. Biochem. pmid:20589831
Li R et al. [Analysis of the nasopharyngeal aspirates in children with different severities of bronchiolitis]. 2010 Zhongguo Dang Dai Er Ke Za Zhi pmid:20497653
Lieber G et al. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat. 2010 Pharmacology pmid:20453555
Wunder F et al. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor. 2010 Br. J. Pharmacol. pmid:20423349
Julius P et al. sCD14 in bronchoalveolar lavage 18, 42 and 162 hours after segmental allergen provocation. 2010 Scand. J. Immunol. pmid:20384875
Zhou G et al. Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway. 2010 Cardiology pmid:20234134
Schäper C et al. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis. 2009 J Investig Allergol Clin Immunol pmid:20128420
Woszczek G et al. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists. 2010 J. Immunol. pmid:20083671
Itagaki K et al. Eicosanoid-induced store-operated calcium entry in dendritic cells. 2011 J. Surg. Res. pmid:20080257
Cai BL et al. [Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds]. 2009 Zhejiang Da Xue Xue Bao Yi Xue Ban pmid:20014485
Finkensieper A et al. The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells. 2010 Cardiovasc. Res. pmid:19965960
Farias S et al. Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury. 2009 J. Neurotrauma pmid:19886806
Kim SH et al. Regulation of monocyte chemoattractant protein 1 by cysteinyl leukotriene D4 in human lung epithelial A549 cells. 2009 Ann. Allergy Asthma Immunol. pmid:19852204
Thivierge M et al. Cysteinyl-leukotriene receptor type 1 expression and function is down-regulated during monocyte-derived dendritic cell maturation with zymosan: involvement of IL-10 and prostaglandins. 2009 J. Immunol. pmid:19846883
Lee SJ et al. 4-Hydroxynonenal enhances MMP-9 production in murine macrophages via 5-lipoxygenase-mediated activation of ERK and p38 MAPK. 2010 Toxicol. Appl. Pharmacol. pmid:19837106
Mezhybovska M et al. Beta-catenin is involved in alterations in mitochondrial activity in non-transformed intestinal epithelial and colon cancer cells. 2009 Br. J. Cancer pmid:19826421
Muraki M et al. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication. 2009 Int. Immunopharmacol. pmid:19706339
Meliton AY et al. Leukotriene D4 activates {beta}2-integrin adhesion in human polymorphonuclear leukocytes. 2010 Eur. Respir. J. pmid:19679609
Austen KF et al. The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications. 2009 J. Allergy Clin. Immunol. pmid:19647860
Pugliese AM et al. Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPgammaS binding and electrophysiological studies in 1321N1 cells. 2009 Am. J. Physiol., Cell Physiol. pmid:19625605
Hori M et al. NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects. 2009 Eur. J. Pharmacol. pmid:19616537
Yang HS et al. [Effects of leukotriene receptor antagonists on vascular endothelial growth factor and its receptors in a sensitized rat model]. 2009 Zhonghua Jie He He Hu Xi Za Zhi pmid:19575935
Maekawa A et al. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19561298
Mori M et al. Eosinophil superoxide anion generation induced by adhesion molecules and leukotriene D4. 2009 Int. Arch. Allergy Immunol. pmid:19494502
Lee TH et al. Leukotriene E4: perspective on the forgotten mediator. 2009 J. Allergy Clin. Immunol. pmid:19482346
Boehmler AM et al. The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells. 2009 J. Immunol. pmid:19454674
Baker N et al. Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. 2009 J. Immunol. pmid:19265161
Yuan YM et al. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway. 2009 J. Pharmacol. Sci. pmid:19234368
Campos MR et al. Differential kinase requirement for enhancement of Fc gammaR-mediated phagocytosis in alveolar macrophages by leukotriene B4 vs. D4. 2009 Mol. Immunol. pmid:19223078
Hashimoto K et al. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways. 2009 Int. Arch. Allergy Immunol. pmid:19218821
Theron AJ et al. Leukotrienes C4 and D4 sensitize human neutrophils for hyperreactivity to chemoattractants. 2009 Inflamm. Res. pmid:19184354
Broom OJ and Nielsen OH [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine]. 2009 Ugeskr. Laeg. pmid:19174041
Claesson HE On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma. 2009 Prostaglandins Other Lipid Mediat. pmid:19130894
Fang SH et al. Pranlukast attenuates ischemia-like injury in endothelial cells via inhibiting reactive oxygen species production and nuclear factor-kappaB activation. 2009 J. Cardiovasc. Pharmacol. pmid:19129732
Dayyat E et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. 2009 Chest pmid:19118273
Lee SP et al. Crosstalk between prostaglandin E2 and leukotriene B4 regulates phagocytosis in alveolar macrophages via combinatorial effects on cyclic AMP. 2009 J. Immunol. pmid:19109185
Selg E et al. Two different mechanisms for modulation of bronchoconstriction in guinea-pigs by cyclooxygenase metabolites. 2009 Prostaglandins Other Lipid Mediat. pmid:19103301
Schain F et al. Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas. 2008 Clin Lymphoma Myeloma pmid:19064398
Yudina Y et al. Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells. 2008 Prostaglandins Leukot. Essent. Fatty Acids pmid:19042113
Mizutani N et al. Effect of TA-270, a novel quinolinone derivative, on antigen-induced nasal blockage in a guinea pig model of allergic rhinitis. 2009 Eur. J. Pharmacol. pmid:19022242
Lecca D et al. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. 2008 PLoS ONE pmid:18974869
Maekawa A et al. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18931305
Rehni AK et al. Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. 2008 Eur. J. Pharmacol. pmid:18840427
Schain F et al. Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma. 2008 Int. J. Cancer pmid:18704935
Tamaoka M et al. The epidermal growth factor receptor mediates allergic airway remodelling in the rat. 2008 Eur. Respir. J. pmid:18653647
pmid:18651869
Claesson HE et al. Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma. 2008 FEBS J. pmid:18647347
Taylor-Clark TE et al. Leukotriene D4 increases the excitability of capsaicin-sensitive nasal sensory nerves to electrical and chemical stimuli. 2008 Br. J. Pharmacol. pmid:18500362
Woszczek G et al. IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells. 2008 J. Immunol. pmid:18490762
Talukder JR et al. Mechanism of leukotriene D4 inhibition of Na-alanine cotransport in intestinal epithelial cells. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18436626
Paruchuri S et al. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. 2008 J. Biol. Chem. pmid:18411276
Thompson C et al. Leukotriene D4 up-regulates furin expression through CysLT1 receptor signaling. 2008 Am. J. Respir. Cell Mol. Biol. pmid:18323532
Ito Y et al. Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4. 2008 BMB Rep pmid:18315950
Profita M et al. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion. 2008 J. Pharmacol. Exp. Ther. pmid:18305014
Macdonald D et al. Substituted 2,2-bisaryl-bicycloheptanes as novel and potent inhibitors of 5-lipoxygenase activating protein. 2008 Bioorg. Med. Chem. Lett. pmid:18276139
Wienkötter N et al. The effect of nigellone and thymoquinone on inhibiting trachea contraction and mucociliary clearance. 2008 Planta Med. pmid:18219598
Mizutani N et al. Involvement of peroxynitrite in pollen-induced nasal blockage in guinea pigs. 2008 Eur. J. Pharmacol. pmid:18191833
Suzuki S et al. Leukotriene D4 upregulates MUC2 gene transcription in human epithelial cells. 2008 Pharmacology pmid:18176092
Ge H et al. Elucidation of signaling and functional activities of an orphan GPCR, GPR81. 2008 J. Lipid Res. pmid:18174606
Bengtsson AM et al. Leukotriene D(4) induces AP-1 but not NFkappaB signaling in intestinal epithelial cells. 2008 Prostaglandins Other Lipid Mediat. pmid:18083053
Ishimura M et al. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs. 2008 Br. J. Pharmacol. pmid:18037905
Woszczek G et al. Leukotriene D(4) induces gene expression in human monocytes through cysteinyl leukotriene type I receptor. 2008 J. Allergy Clin. Immunol. pmid:18028998
Bossé Y et al. Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation. 2008 Clin. Exp. Allergy pmid:18028462
Lötzer K et al. 5-Lipoxygenase/cyclooxygenase-2 cross-talk through cysteinyl leukotriene receptor 2 in endothelial cells. 2007 Prostaglandins Other Lipid Mediat. pmid:17991613
Shirasaki H et al. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes. 2007 Ann. Allergy Asthma Immunol. pmid:17941281
Peres CM et al. Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. 2007 J. Immunol. pmid:17911632
Huang XJ et al. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation. 2008 Glia pmid:17910051
Morishima H et al. Ligation of Toll-like receptor 3 differentially regulates M2 and M3 muscarinic receptor expression and function in human airway smooth muscle cells. 2008 Int. Arch. Allergy Immunol. pmid:17851256